Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | MGAM | O43451 | 1/20 | 0.31 |
| ▸ | SI | P14410 | 1/20 | 0.31 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3069770 | 0.80 | GAA (0.34) | GAAALDH1A1MEN1TSHRKMT2A | |
| SCHEMBL581442 | 0.80 | GAA (0.34) | GAAALDH1A1MEN1TSHRKMT2A | |
| SCHEMBL587241 | 0.80 | GAA (0.34) | GAAALDH1A1MEN1TSHRKMT2A | |
| SCHEMBL581347 | 0.79 | GAA (0.39) | GAAALDH1A1TSHRMGAMSI | |
| SCHEMBL3077003 | 0.79 | GAA (0.39) | GAAALDH1A1TSHRMGAMSI | |
| SCHEMBL3082880 | 0.79 | GAA (0.39) | GAAALDH1A1TSHRMGAMSI | |
| SCHEMBL3088433 | 0.79 | GAA (0.35) | GAAALDH1A1MEN1TSHRKMT2A | |
| SCHEMBL3079270 | 0.79 | GAA (0.35) | GAAALDH1A1MEN1TSHRKMT2A | |
| SCHEMBL580755 | 0.79 | GAA (0.35) | GAAALDH1A1MEN1TSHRKMT2A | |
| SCHEMBL14698755 | 0.77 | GAA (0.35) | GAAALDH1A1MEN1TSHRKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2417131-A1 | ISOXAZOL-3(2H)-ONE ANALOGS AS THERAPEUTIC AGENTS | AstraZeneca AB (SE) | 2012-02-15 | — | — | EP | disclosed |
| WO-2010117323-A1 | METHOD AND APPARATUS FOR PRODUCING HEAT ENERGY AND CARBON DIOXIDE | ASTRAZENECA AB (SE) | 2010-10-14 | — | — | WO | disclosed |